Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Company News
RPG Life Sciences Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value(
)
532983
INE105J01010
229.3856146
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
RPGLIFE
37.72
3284.73
EPS(TTM)
Face Value(
)
Div & Yield %:
52.65
8
0.81
Back
Indian Sucrose Ltd
Indian Sucrose Ltd - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30 2024 Along With The Limited Review Report Of The Auditors Thereon
Aug 07,2024
INDIAN SUCROSE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve Unaudited Financial Results For The Quarter Ended June 30 2024 Along With The Limited Review Report Of The Auditors Thereon and to Transact any other business with the permission of the chair.